Cargando…
Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder
Introduction: Response to treatment, according to Clinical Global Impression-Improvement (CGI-I) scale, is an easily interpretable outcome in clinical trials of autism spectrum disorder (ASD). Yet, the CGI-I rating is sometimes reported as a continuous outcome, and converting it to dichotomous would...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305379/ https://www.ncbi.nlm.nih.gov/pubmed/34356141 http://dx.doi.org/10.3390/brainsci11070908 |
_version_ | 1783727560592457728 |
---|---|
author | Siafis, Spyridon Rodolico, Alessandro Çıray, Oğulcan Murphy, Declan G. Parellada, Mara Arango, Celso Leucht, Stefan |
author_facet | Siafis, Spyridon Rodolico, Alessandro Çıray, Oğulcan Murphy, Declan G. Parellada, Mara Arango, Celso Leucht, Stefan |
author_sort | Siafis, Spyridon |
collection | PubMed |
description | Introduction: Response to treatment, according to Clinical Global Impression-Improvement (CGI-I) scale, is an easily interpretable outcome in clinical trials of autism spectrum disorder (ASD). Yet, the CGI-I rating is sometimes reported as a continuous outcome, and converting it to dichotomous would allow meta-analysis to incorporate more evidence. Methods: Clinical trials investigating medications for ASD and presenting both dichotomous and continuous CGI-I data were included. The number of patients with at least much improvement (CGI-I ≤ 2) were imputed from the CGI-I scale, assuming an underlying normal distribution of a latent continuous score using a primary threshold θ = 2.5 instead of θ = 2, which is the original cut-off in the CGI-I scale. The original and imputed values were used to calculate responder rates and odds ratios. The performance of the imputation method was investigated with a concordance correlation coefficient (CCC), linear regression, Bland–Altman plots, and subgroup differences of summary estimates obtained from random-effects meta-analysis. Results: Data from 27 studies, 58 arms, and 1428 participants were used. The imputation method using the primary threshold (θ = 2.5) had good performance for the responder rates (CCC = 0.93 95% confidence intervals [0.86, 0.96]; β of linear regression = 1.04 [0.95, 1.13]; bias and limits of agreements = 4.32% [−8.1%, 16.74%]; no subgroup differences χ(2) = 1.24, p-value = 0.266) and odds ratios (CCC = 0.91 [0.86, 0.96]; β = 0.96 [0.78, 1.14]; bias = 0.09 [−0.87, 1.04]; χ(2) = 0.02, p-value = 0.894). The imputation method had poorer performance when the secondary threshold (θ = 2) was used. Discussion: Assuming a normal distribution of the CGI-I scale, the number of responders could be imputed from the mean and standard deviation and used in meta-analysis. Due to the wide limits of agreement of the imputation method, sensitivity analysis excluding studies with imputed values should be performed. |
format | Online Article Text |
id | pubmed-8305379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83053792021-07-25 Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder Siafis, Spyridon Rodolico, Alessandro Çıray, Oğulcan Murphy, Declan G. Parellada, Mara Arango, Celso Leucht, Stefan Brain Sci Brief Report Introduction: Response to treatment, according to Clinical Global Impression-Improvement (CGI-I) scale, is an easily interpretable outcome in clinical trials of autism spectrum disorder (ASD). Yet, the CGI-I rating is sometimes reported as a continuous outcome, and converting it to dichotomous would allow meta-analysis to incorporate more evidence. Methods: Clinical trials investigating medications for ASD and presenting both dichotomous and continuous CGI-I data were included. The number of patients with at least much improvement (CGI-I ≤ 2) were imputed from the CGI-I scale, assuming an underlying normal distribution of a latent continuous score using a primary threshold θ = 2.5 instead of θ = 2, which is the original cut-off in the CGI-I scale. The original and imputed values were used to calculate responder rates and odds ratios. The performance of the imputation method was investigated with a concordance correlation coefficient (CCC), linear regression, Bland–Altman plots, and subgroup differences of summary estimates obtained from random-effects meta-analysis. Results: Data from 27 studies, 58 arms, and 1428 participants were used. The imputation method using the primary threshold (θ = 2.5) had good performance for the responder rates (CCC = 0.93 95% confidence intervals [0.86, 0.96]; β of linear regression = 1.04 [0.95, 1.13]; bias and limits of agreements = 4.32% [−8.1%, 16.74%]; no subgroup differences χ(2) = 1.24, p-value = 0.266) and odds ratios (CCC = 0.91 [0.86, 0.96]; β = 0.96 [0.78, 1.14]; bias = 0.09 [−0.87, 1.04]; χ(2) = 0.02, p-value = 0.894). The imputation method had poorer performance when the secondary threshold (θ = 2) was used. Discussion: Assuming a normal distribution of the CGI-I scale, the number of responders could be imputed from the mean and standard deviation and used in meta-analysis. Due to the wide limits of agreement of the imputation method, sensitivity analysis excluding studies with imputed values should be performed. MDPI 2021-07-09 /pmc/articles/PMC8305379/ /pubmed/34356141 http://dx.doi.org/10.3390/brainsci11070908 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Siafis, Spyridon Rodolico, Alessandro Çıray, Oğulcan Murphy, Declan G. Parellada, Mara Arango, Celso Leucht, Stefan Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder |
title | Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder |
title_full | Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder |
title_fullStr | Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder |
title_full_unstemmed | Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder |
title_short | Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder |
title_sort | imputing the number of responders from the mean and standard deviation of cgi-improvement in clinical trials investigating medications for autism spectrum disorder |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305379/ https://www.ncbi.nlm.nih.gov/pubmed/34356141 http://dx.doi.org/10.3390/brainsci11070908 |
work_keys_str_mv | AT siafisspyridon imputingthenumberofrespondersfromthemeanandstandarddeviationofcgiimprovementinclinicaltrialsinvestigatingmedicationsforautismspectrumdisorder AT rodolicoalessandro imputingthenumberofrespondersfromthemeanandstandarddeviationofcgiimprovementinclinicaltrialsinvestigatingmedicationsforautismspectrumdisorder AT cırayogulcan imputingthenumberofrespondersfromthemeanandstandarddeviationofcgiimprovementinclinicaltrialsinvestigatingmedicationsforautismspectrumdisorder AT murphydeclang imputingthenumberofrespondersfromthemeanandstandarddeviationofcgiimprovementinclinicaltrialsinvestigatingmedicationsforautismspectrumdisorder AT parelladamara imputingthenumberofrespondersfromthemeanandstandarddeviationofcgiimprovementinclinicaltrialsinvestigatingmedicationsforautismspectrumdisorder AT arangocelso imputingthenumberofrespondersfromthemeanandstandarddeviationofcgiimprovementinclinicaltrialsinvestigatingmedicationsforautismspectrumdisorder AT leuchtstefan imputingthenumberofrespondersfromthemeanandstandarddeviationofcgiimprovementinclinicaltrialsinvestigatingmedicationsforautismspectrumdisorder |